01 — At a Glance
The Pipe Dream That’s Actually Delivering
- 52-Week High / Low₹1,705 / ₹1,232
- Q3 FY26 Revenue₹1,542 Cr
- Q3 FY26 PAT₹120 Cr
- Q3 FY26 EPS₹4.01
- Annualised EPS (Q3×4)₹16.04
- Book Value₹141
- Price to Book12.0x
- Dividend Yield0.22%
- Debt / Equity0.07x
- FY25 Full Year EPS₹19.50
Auditor’s Opening Note: Astral posted Q3 FY26 revenue of ₹1,542 crore (+10.3% YoY), PAT of ₹120 crore (+5.18% YoY), and — here’s the kicker — 17% volume growth in plumbing with 18.2% EBITDA margins. This in an industry where polymer prices were doing their best impression of a moody teenager: volatile, unpredictable, and exhausting. Meanwhile, the stock P/E of 88.1x is screaming “expensive,” but the company is sitting on zero debt and is about to commission a backward-integrated CPVC plant that’ll transform unit economics. Translation: the market is pricing in a future that actually looks promising.
02 — Introduction
When Your Pipes Have More Attitude Than Your Analyst
Astral Ltd manufactures plastic pipes, plumbing systems, adhesives, and paints. That’s it. No AI. No SaaS. No “platform.” Just plastic pipes delivered to 251,000 dealers, 3,610 distributors, and 52 sales depots across India. And yet — in an environment where the polymer industry is getting absolutely murdered by price volatility and demand destruction — Astral is delivering industry-leading growth with margins that would make most competitors weep into their PVC pellets.
Founded in 1996 by Sandeep Engineer (who’s now chairman and managing director), the company has a 51% market share in automotive lubricants— wait, no, that’s Castrol. Astral has a dominant position in CPVC pipes, launched the first CPVC piping system in India in 1999, and has been systematically building an empire of distribution, brand recognition, and product innovation ever since.
Q3 FY26 was a masterclass in execution under chaos. Polymer prices tanked, inventory losses piled up, government spending dried up, and somehow Astral still managed 17% volume growth with healthy margins. The management is bullish on Q4, and the data from January and February backs it up. Better yet, a backward-integrated CPVC plant is coming online in FY27, which will dramatically improve unit economics on the company’s highest-margin product.
New manufacturing plants in Hyderabad and Kanpur are ramping up. A paint business hitting 21.6% growth. An adhesive business growing at 14% with 17.3% EBITDA margins. And a CEO who’s brutally honest on concalls about what’s working and what’s not. Let’s dig in.
Concall Highlight (Feb 2026): “We are balancing the volume growth also and we are balancing the bottom line also.” Management explicitly rejected price-gouging in Q4 despite PVC price recovery. This is the behaviour of a company playing the long game.
03 — Business Model: WTF Do They Even Do?
Plastic Pipes, Adhesives, and the Occasional Paint Business That’s Actually Growing
Astral operates three core business verticals. The plumbing segment (72% of revenue) is the heavyweight champion: PVC, CPVC, and lead-free plastic piping systems for residential, commercial, and industrial applications. Think drainage systems, water supply, agriculture, fire sprinklers, electrical conduits. The adhesive segment (19% of revenue) sells sealants and adhesives for construction, automotive, furniture, and insulation. The paint segment (9% of revenue) is the scrappy underdog that’s growing like mad.
Market position: 51% market share in CPVC pipes (the Rolls-Royce of plastic pipes, with 300–400 bps margin premium over PVC). ~40% in other categories. Distribution depth of 3,610+ distributors and 251,000+ dealers. Manufacturing footprint of 26 plants across India (plus international operations). Capacity of 381,957 MTPA for pipes and water tanks, 131,000 MTPA for adhesives, and 36,000 MTPA for paints.
Expansion playbook: The company spent ₹1,400 crore on capex over the last four years, commissioned new plants in Hyderabad (now at 50–55% utilization) and Kanpur (response has been “very good”), and is gearing up for a backward-integrated CPVC resin plant that’ll cost ₹120 crore and come online in Q3–Q4 FY27. This will unlock margin expansion and reduce supply chain risk on the company’s highest-margin product.
CPVC Dominance51%Market Share
Adhesive Growth14%YoY (Q3)
Paint Growth21.6%YoY (Q3)
Dealer Network251,000Distribution Reach
Product Mix Reality Check: Astral is no longer a “pipes only” company. Adhesives are growing 14% with 17.3% margins. Paints are growing 21.6% while being integrated into new geographies (West, South). Bathware is ramping up with 36.5% growth. The company is deliberately de-risking from commodity pipes by building a portfolio of higher-margin, faster-growing adjacencies.
💬 Does your house have Astral pipes running through it? Did you know you’re part of a 251,000-dealer distribution network? Drop a comment if your plumber’s favorite brand just got a 17% volume boost!
04 — Financials Overview
Q3 FY26: The Numbers (And The Chaos Behind Them)
Result type: Quarterly Results | Q3 FY26 EPS: ₹4.01 | Annualised EPS (Q3×4): ₹16.04 | FY25 Full Year EPS: ₹19.50
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 1,542 | 1,397 | 1,577 | +10.3% | -2.2% |
| Operating Profit (EBITDA) | 247 | 231 | 278 | +6.9% | -11.2% |
| EBITDA Margin % | 16.0% | 16.5% | 17.6% | -50 bps | -160 bps |
| PAT | 120 | 114 | 135 | +5.2% | -11.1% |
| EPS (₹) | 4.01 | 4.25 | 5.02 | -5.6% | -20.1% |
The Real Story Behind The Numbers: Yes, PAT and EPS are down YoY. But here’s the context management provided on concall: Q3 FY26 includes 20–25 crore in inventory losses from the collapse in PVC/CPVC prices during the quarter. That’s a one-time hit. The underlying business is actually accelerating — 17% volume growth in plumbing with 18.2% EBITDA margins (ex-inventory loss). Strip out the inventory pain and normalize for it, and this quarter looks materially better than the headline EPS suggests. Management expects to reverse this inventory loss in Q4 if PVC prices remain stable (they’ve already started recovering).
05 — Valuation Discussion
Fair Value Range: Separating The Hype From The Hope
Join 10,000+ investors who read this every week.
